✦ LIBER ✦

Economic Evaluation of Third-Line Treatment with Alemtuzumab for Chronic Lymphocytic Leukaemia

✍ Scribed by Dr W. Guy Scott, Helen M. Scott

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Population pharmacokinetics–pharmacodyna

✍ D. R. Mould; A. Baumann; J. Kuhlmann; M. J. Keating; S. Weitman; P. Hillmen; L. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 867 KB

Cellular immune reconstitution after sub

✍ Lundin, J; Porwit-MacDonald, A; Rossmann, E D; Karlsson, C; Edman, P; Rezvany, M 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 143 KB

PCN70 TREATMENT OF CHRONIC LYMPHOCYTIC L

✍ MJ Keating; S Lerner; R Aultman 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

Reconstitution of the T-cell repertoire

✍ Mohammad Reza Rezvany; Mahmood Jeddi Tehrani; Claes Karlsson; Jeanette Lundin; H 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB

PCN88 AN ECONOMIC EVALUATION OF RITUXIMA

✍ P Kawalec; E Stawowczyk; M Russel-Szymczyk; M Szkultecka-Debek; R Aultman; E Car 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PCN90 Cost Effectiveness Analysis of Ben

✍ S. Vandekerckhove; K. Holtzer-Goor; D. Van Den Steen; Y. van Megen; P. Huijgens; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB